| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |